Akèy › Maladi Alzheimer › Massachusetts
Etid klinik pou Maladi Alzheimer nan Massachusetts
45 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Boston Center for Memory, Newton
- Local Institution - 2615, Worcester
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- Brigham and Women's Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT00869817A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- ActivMed Practices & Research, LLC, Methuen
- Adams Clinical - Watertown, Watertown
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
- 111 Cummington Mall. Room 264, Boston
Ap rekriteVolontè an sante akeyi
Laj 50 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT06094192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Massachusetts General Hospital - Charlestown, Charlestown
- K2 Medical Research - Foxborough, Foxborough
- Neurology Center of New England, Foxborough
- ak 1 plis
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Boston Center for Memory - Newton- Site Number : 8400007, Newton
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- McLean Hospital, Belmont
- Tufts Medical Center - 800 Washington St - PPDS, Boston
- Boston Neuro Research Center, North Dartmouth
- ak 1 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Adams Clinical Boston, Boston
- Headlands Research-EMA, Plymouth
- Adams Clinical Watertown, Watertown
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Adams Clinical Boston, Boston
- Boston Center for Memory, Newton
- Adams Clinical Watertown, Watertown
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Adams Clinical /ID# 277754, Watertown
Ap rekriteFaz 1/2
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0080, Watertown
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1663, Foxborough
- Boston Center for Memory, Newton
- Mayflower Clinical Research, South Dartmouth
- ak 1 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011732The BRAIN App (Phase 2 SBIR)
- Hopeful Aging, Winchester
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06298474Making Connections Thru Music
- Hopeful Aging, Winchester
- The Hearthstone Institute, LLC, Winchester
Ap rekriteVolontè an sante akeyi
Laj 18 a 103 · Tout sèks · Mizajou Sep 15, 2026 · NCT06079216Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 4, 2026 · NCT05658913Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- K2 Medical Research, Foxborough
- Local Institution - 0051, South Dartmouth
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT04124029A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Boston Center for Memory ( Site 1008), Newton
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Boston Center for Memory, Newton
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- Boston University Neuromotor Recovery Laboratory, Boston
Ap rekriteVolontè an sante akeyi
Laj 50 a 90 · Tout sèks · Mizajou Aug 13, 2026 · NCT07659964Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
- Hebrew Rehabilitation Center, Roslindale
Ap rekrite
Laj 65 a 90 · Tout sèks · Mizajou Jul 16, 2026 · NCT06821568Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
- Massachusetts General Hospital, Charlestown
Ap rekriteVolontè an sante akeyi
Laj 50 a 80 · Tout sèks · Mizajou Jul 14, 2026 · NCT05904132A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Boston Center for Memory, Newton
- MedVadis Research Corporation, Waltham
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- ActivMed Practices and Research, Methuen
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease
- Massachusetts General Hospital, Boston
- Massachusetts Institute of Technology, Cambridge
Ap rekriteVolontè an sante akeyi
Laj 55 a 90 · Tout sèks · Mizajou Jun 18, 2026 · NCT05776641Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT07236190[18F]PI-2620 Phase 3 Histopathological Study
- Alzheimer's Disease Center, Braintree
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Massachusetts General Hospital, Co-Enrolling through ABC-DS Only, Boston
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
- Massachusetts General Hospital, Boston
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 40 a 99 · Tout sèks · Mizajou May 6, 2026 · NCT06538311Cognitive Neurology Unit Clinical Registry
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteEtid obsèvasyon
Laj 50 a 95 · Tout sèks · Mizajou Apr 13, 2026 · NCT05925621Gamma Frequency Stimulation in Individuals With Down Syndrome
- Massachusetts Institute of Technology, Cambridge
Ap rekriteVolontè an sante akeyi
Laj 25 a 65 · Tout sèks · Mizajou Mar 31, 2026 · NCT05196984Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
- Massachusetts Institute of Technology, Cambridge
Ap rekriteVolontè an sante akeyi
Laj 65 a 100 · Tout sèks · Mizajou Mar 30, 2026 · NCT05655195Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)
- MIT, Cambridge
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Mar 27, 2026 · NCT07496918Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Mar 6, 2026 · NCT05881239Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston
Ap rekriteFaz 2
Laj 60 a 85 · Tout sèks · Mizajou Feb 12, 2026 · NCT06489548PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
- Brigham MS Center, 60 Fenwood Road, Boston
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Jan 28, 2026 · NCT02649985Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- Hinda and Arthur Marcus Institute for Aging Research, Boston
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT05661084Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
- Hebrew SeniorLife, Boston
Ap rekrite
Laj 60 a 106 · Tout sèks · Mizajou Jan 6, 2026 · NCT05950607Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.